IL17A and thymoma: It is therefore possible that anti-cytokine antibodies are generated due to defective peripheral expression of Aire. However, it should be noted that patients with thymomas can produce anti-IL-17 and anti-IFN antibodies, consistent with AIRE’s role in modulating central immune tolerance [60].